Compelo Medical Devices - Latest industry news and analysis is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

Medasys Prometra implantable drug pump wins FDA PMA approval

The US Food and Drug Administration (FDA) has granted a premarket approval (PMA) to Medasys' Prometra programmable implantable drug pump.

Prometra is a non-peristaltic programmable implantable pump which delivers Infumorph (preservative-free morphine sulfate sterile solution) intraspinally to manage pain.

The Prometra also uses a patented valve gated precision dosing system to achieve extremely high accuracy, minimize dose variations due to temperature, pressure, flow rate, or reservoir fill levels.

Medasys said a clinical trial also showed 97% clinical accuracy in the delivery of the physician-programmed dose.